2025 EXPERT SPEAKER FACULTY

Amitha Domalpally, 3rd Retinal Imaging Biomarkers & Endpoints Summit, ophthalmology conference

Amitha Domalpally

Assistant Professor & Director

University of Wisconsin-Madison

Archana Nigalye, 3rd Retinal Imaging Biomarkers & Endpoints Summit, ophthalmology conference

Archana Nigalye

Associate Director - Medical

Alexion

Ash Jayagopal - Opus Genetics, 3rd Retinal Imaging Biomarkers & Endpoints Summit, ophthalmology conference

Ash Jayagopal

Chief Scientific & Development Officer

Opus Genetics

Brian Levy - Ocunexus Therapeutics, 3rd Retinal Imaging Biomarkers & Endpoints Summit, ophthalmology conference

Brian Levy

Chief Executive Officer

InflammX

Bright Senyo, Apellis Pharmaceuticals, 3rd Retinal Imaging Biomarkers & Endpoints Summit, ophthalmology conference

Bright Senyo Ashimatey

Clinical Research and Development Scientist

Apellis Pharmaceuticals

Cyril Eleftheriou - Novartis, 3rd Retinal Imaging Biomarkers & Endpoints Summit, ophthalmology conference

Cyril Eleftheriou

Imaging Scientist

Boston Image Reading Center

Daniil Gataulin - Chardan, 3rd Retinal Imaging Biomarkers & Endpoints Summit, ophthalmology conference

Daniil Gataulin

Senior Research Analyst

Chardan Capital Markets

Kenji Fujita - Atsena Therapeutics, 3rd Retinal Imaging Biomarkers & Endpoints Summit, ophthalmology conference

Kenji Fujita

Chief Medical Officer

Atsena Therapeutics

Laure Blouin - SparingVision, 3rd Retinal Imaging Biomarkers & Endpoints Summit, ophthalmology conference

Laure Blouin

Senior Director of Clinical Science and Medical Communication

SparingVision

Francesca Cordeiro - UCL, 3rd Retinal Imaging Biomarkers & Endpoints Summit, ophthalmology conference

M Francesca Cordeiro

Professor Imperial College London, UCL, ICORG, Western Eye Hospital & Founder Novai Ltd

University College London - UCL

Maryam Mokhtarzadeh - REGENXBIO, 3rd Retinal Imaging Biomarkers & Endpoints Summit, ophthalmology conference

Maryam Mokhtarzadeh

Sr Director Regulatory Strategy

REGENXBIO

Mayssa Attar - Bausch + Lomb, 3rd Retinal Imaging Biomarkers & Endpoints Summit, ophthalmology conference

Mayssa Attar

Senior Vice President & Head of Pharmaceutical, Consumer Research & Development

Bausch + Lomb

Mohammad Eslami - Harvard Medical School, 3rd Retinal Imaging Biomarkers & Endpoints Summit, ophthalmology conference

Mohammad Eslami

Instructor

Harvard Medical School

Najam Sharif - Nanoscope Therapeutics, 3rd Retinal Imaging Biomarkers & Endpoints Summit, ophthalmology conference

Najam Sharif

Vice President, Global Research & Development

Nanoscope Therapeutics Inc

Shelley Boyd - Translatum Medicus, 3rd Retinal Imaging Biomarkers & Endpoints Summit, ophthalmology conference

Shelley Boyd

Chief Executive Officer

Translatum Medicus

Tara DeSilva - Cleveland Clinic, 3rd Retinal Imaging Biomarkers & Endpoints Summit, ophthalmology conference

Tara DeSilva

Associate Professor

Cleveland Clinic Taussig Cancer Institute

Touseef Qureshi - Cedar's Sinai Medical Center, 3rd Retinal Imaging Biomarkers & Endpoints Summit, ophthalmology conference

Touseef Qureshi

Assistant Professor

Cedars-Sinai Medical Center

WeiWei Lou, Merck, 3rd Retinal Imaging Biomarkers & Endpoints Summit, ophthalmology conference

Weiwei Luo

Principal Scientist

Merck & Co

Yaniv Barkana - Galimedix, 3rd Retinal Imaging Biomarkers & Endpoints Summit, ophthalmology conference

Yaniv Barkana

Chief Medical Officer

Galimedix

VIEW THE 2025 AGENDA